NASDAQ
Ionis Pharmaceuticals, Inc. (IONS) has a price/sales ratio of 13.41x as of Friday, May 22, 2026. This represents a 72.94% increase compared to its 12-month average of 7.75x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.